PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation.
EMBO J
; 43(14): 2929-2953, 2024 Jul.
Article
en En
| MEDLINE
| ID: mdl-38834853
ABSTRACT
PARP-catalysed ADP-ribosylation (ADPr) is important in regulating various cellular pathways. Until recently, PARP-dependent mono-ADP-ribosylation has been poorly understood due to the lack of sensitive detection methods. Here, we utilised an improved antibody to detect mono-ADP-ribosylation. We visualised endogenous interferon (IFN)-induced ADP-ribosylation and show that PARP14 is a major enzyme responsible for this modification. Fittingly, this signalling is reversed by the macrodomain from SARS-CoV-2 (Mac1), providing a possible mechanism by which Mac1 counteracts the activity of antiviral PARPs. Our data also elucidate a major role of PARP9 and its binding partner, the E3 ubiquitin ligase DTX3L, in regulating PARP14 activity through protein-protein interactions and by the hydrolytic activity of PARP9 macrodomain 1. Finally, we also present the first visualisation of ADPr-dependent ubiquitylation in the IFN response. These approaches should further advance our understanding of IFN-induced ADPr and ubiquitin signalling processes and could shed light on how different pathogens avoid such defence pathways.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Interferones
/
Poli(ADP-Ribosa) Polimerasas
/
Ubiquitina-Proteína Ligasas
/
ADP-Ribosilación
Límite:
Humans
Idioma:
En
Revista:
EMBO J
Año:
2024
Tipo del documento:
Article
Pais de publicación:
Reino Unido